You are using an older browser version. Please use a supported version for the best MSN experience.

Pfizer-BioNTech says its COVID-19 vaccine safe, effective in kids aged 5-11

Pfizer and BioNTech say their COVID-19 vaccine induced a robust immune response in five- to 11-year-olds. They plan to seek approval to use the vaccine in children in that age range in the U.S., Europe and elsewhere as soon as possible.
image beaconimage beaconimage beacon